Earlier this week, investment bank Wedbush identified Palantir Technologies (PLTR) as a top pick for the AI revolution in 2025. Wedbush expects Palantir’s AI platform to gain traction among ...

Microsoft (NASDAQ:MSFT – Get Free Report)‘s stock had its “outperform” rating reaffirmed by investment analysts at Wedbush in ...

Like the bulk of the tech market, Microsoft shares have come under pressure recently as investors remain skeptical about ...

In a report released today, Nick Setyan from Wedbush maintained a Hold rating on Lennar (LEN – Research Report), with a price target of ...

Wedbush analyst Nick Setyan reiterated a Buy rating on Darden Restaurants (DRI – Research Report) today and set a price target of $235.00. The ...

Tesla’s (TSLA) stock is in the midst of its longest losing streak since going public 15 years ago, with shares falling for ...

Wedbush Securities is making a big statement on Tesla (NASDAQ:TSLA), naming it to its Best Ideas List even though the stock has had a rough start to the year. According to analyst Dan Ives, Tesla ...

Avalo Therapeutics (NASDAQ:AVTX – Get Free Report)‘s stock had its “outperform” rating reiterated by Wedbush in a report ...

Wedbush Securities backed its Outperform rating on Tesla (NASDAQ:TSLA) and $550 price target on Thursday, although the firm ...

Nvidia (NVDA) is climbing slightly after investment bank Wedbush Securities predicted that the chip maker would deliver "clear beat-and-raise" financial results later this week. Why Wedbush ...

Shares of Avalo Therapeutics (NASDAQ:AVTX) climbed on Friday as Wedbush launched its coverage with an Outperform recommendation and an $18 per share target, citing the potential of the biotech’s ...